lifibrol has been researched along with phenyl acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, FP; St John, LC | 1 |
| Bell, FP | 1 |
2 other study(ies) available for lifibrol and phenyl acetate
| Article | Year |
|---|---|
Action of the new hypolipidemic agent lifibrol (K12.148) on lipid homeostasis in normal rats: plasma lipids, hepatic sterologenesis, and the fate of injected [14C]acetate.
Topics: Acetates; Animals; Butanols; Homeostasis; Hydroxybenzoates; Hypolipidemic Agents; In Vitro Techniques; Injections, Intraperitoneal; Lipid Metabolism; Lipids; Liver; Male; Rats; Rats, Sprague-Dawley; Reference Values; Sterols | 1993 |
Effect of the lipid-lowering drug lifibrol on lipid metabolism in rat macrophages and in atherosclerotic arteries from swine and WHHL rabbits, in vitro. Implications in atherogenesis.
Topics: Acetates; Animals; Aorta; Arteries; Arteriosclerosis; Butanols; Carbon Radioisotopes; Cholesterol; Hydroxybenzoates; Hyperlipidemias; Hypolipidemic Agents; Lipids; Macrophages, Peritoneal; Male; Oleic Acid; Oleic Acids; Rabbits; Rats; Rats, Sprague-Dawley; Swine | 1993 |